Nykode Therapeutics ASA (NYKD) — Working Capital to Net Assets Ratio
Nykode Therapeutics ASA (NYKD) has a Working Capital to Net Assets ratio of 63.3% as of September 2025. Working capital of Nkr663.93 Million (current assets of Nkr667.83 Million minus current liabilities of Nkr3.91 Million) is measured against net assets of Nkr1.05 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Nykode Therapeutics ASA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Nykode Therapeutics ASA Working Capital to Net Assets (2016–2024)
This chart shows how Nykode Therapeutics ASA's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 63.3%, reflecting working capital of Nkr663.93 Million against net assets of Nkr1.05 Billion NOK. See how many days can Nykode Therapeutics ASA fund operations to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Nykode Therapeutics ASA (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Nykode Therapeutics ASA from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Nykode Therapeutics ASA (NYKD) total market value.
| Year | WC/NA Ratio | Working Capital (NOK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 79.3% | Nkr107.97 Million | Nkr136.21 Million | Nkr117.07 Million | Nkr9.10 Million | ▼ -5.4 pp |
| 2023 | 84.7% | Nkr145.07 Million | Nkr171.26 Million | Nkr165.68 Million | Nkr20.61 Million | ▼ -25.4 pp |
| 2022 | 110.1% | Nkr172.89 Million | Nkr157.02 Million | Nkr211.87 Million | Nkr38.98 Million | ▼ -5.6 pp |
| 2021 | 115.7% | Nkr224.49 Million | Nkr194.06 Million | Nkr255.86 Million | Nkr31.37 Million | ▼ -5.0 pp |
| 2020 | 120.7% | Nkr215.85 Million | Nkr178.85 Million | Nkr229.03 Million | Nkr13.18 Million | ▲ +16.3 pp |
| 2019 | 104.4% | Nkr253.32 Million | Nkr242.56 Million | Nkr291.22 Million | Nkr37.91 Million | ▲ +4.8 pp |
| 2018 | 99.7% | Nkr139.59 Million | Nkr140.07 Million | Nkr152.85 Million | Nkr13.27 Million | ▼ -0.1 pp |
| 2017 | 99.8% | Nkr203.09 Million | Nkr203.53 Million | Nkr214.03 Million | Nkr10.94 Million | ▼ 0.0 pp |
| 2016 | 99.8% | Nkr23.15 Million | Nkr23.19 Million | Nkr24.89 Million | Nkr1.74 Million | — |